Literature DB >> 26565378

Therapeutic drug monitoring: A patient management tool for precision medicine.

S H Jang1, Z Yan1, J A Lazor1.   

Abstract

The precision medicine initiative is designed to better understand the causes of disease, to develop target therapies, and to identify patients that would benefit from treatment. Prescribing the right dose, which is not always the same to all patients, is needed for a successful outcome. The purpose of this commentary is to discuss the role of dose individualization based on therapeutic drug monitoring as a clinical patient management tool in the application of precision medicine.
© 2015 ASCPT.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26565378     DOI： 10.1002/cpt.298

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  9 in total

1.  Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics.

Authors:  Shuyu Lin; Wenzhuo Yu; Bo Wang; Yichao Zhao; Ke En; Jialun Zhu; Xuanbing Cheng; Crystal Zhou; Haisong Lin; Zhaoqing Wang; Hannaneh Hojaiji; Christopher Yeung; Carlos Milla; Ronald W Davis; Sam Emaminejad
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

Review 2.  [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Authors:  Stefan Unterecker; Gudrun Hefner; Pierre Baumann; Gerd Gründer; Niels Bergemann; Hans-Willi Clement; Andreas Conca; Jürgen Deckert; Katharina Domschke; Gabriel Eckermann; Karin Egberts; Manfred Gerlach; Christine Greiner; Ekkehard Haen; Ursula Havemann-Reinecke; Renate Helmer; Ger Janssen; Eveline Jaquenoud; Gerd Laux; Thomas Messer; Rainald Mössner; Matthias J Müller; Michael Paulzen; Bruno Pfuhlmann; Peter Riederer; Alois Saria; Bernd Schoppek; Georgios Schoretsanitis; Markus Schwarz; Margarethe Silva Gracia; Benedikt Stegmann; Werner Steimer; Julia C Stingl; Manfred Uhr; Sven Ulrich; Roland Waschgler; Gerald Zernig; Gabriele Zurek; Christoph Hiemke
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

3.  A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization.

Authors:  Slobodan M Janković
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

4.  Therapeutic drug monitoring in the era of precision medicine: opportunities!

Authors:  Serge Cremers; Nishan Guha; Brian Shine
Journal:  Br J Clin Pharmacol       Date:  2016-10       Impact factor: 4.335

Review 5.  Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management.

Authors:  Rannissa Puspita Jayanti; Nguyen Phuoc Long; Nguyen Ky Phat; Yong-Soon Cho; Jae-Gook Shin
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

6.  Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study.

Authors:  Katrin Ruppert; Christoph Geffert; Hans-Willi Clement; Christian Bachmann; Michael Haberhausen; Eberhard Schulz; Christian Fleischhaker; Monica Biscaldi-Schäfer
Journal:  J Neural Transm (Vienna)       Date:  2022-04-07       Impact factor: 3.850

7.  Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children.

Authors:  Lisa C Martial; Rob E Aarnoutse; Michiel F Schreuder; Stefanie S Henriet; Roger J M Brüggemann; Manuela A Joore
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

Review 8.  The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.

Authors:  Thierry Buclin; Yann Thoma; Nicolas Widmer; Pascal André; Monia Guidi; Chantal Csajka; Laurent A Decosterd
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

9.  "De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug Monitoring.

Authors:  Sarah Baklouti; Peggy Gandia; Didier Concordet
Journal:  Clin Pharmacokinet       Date:  2022-02-04       Impact factor: 5.577
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.